SUBSCRIBE
SUBSCRIBE
News   Business

Zymeworks Appoints Antibody and Drug Development Expert Dr. Paul J. Carter to its Scientific Advisory Board

April 14, 2009 | 
1 min read
VANCOUVER--(BUSINESS WIRE)--Zymeworks Inc., a privately held computational biotechnology company, today announced the appointment of Dr. Paul J. Carter, Chief Scientific Officer of VLST Corp., to its scientific advisory board.
People
Zymeworks, Inc.
MORE ON THIS TOPIC
Illustration showing large scissors cutting employees in half
Layoffs
Kezar Loses 70% of Staff After FDA Cancels Meeting on Autoimmune Asset
November 10, 2025
 · 
2 min read
 · 
Dan Samorodnitsky
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Catalent’s Announced Cuts in Maryland This Year Now Total Over 400 Employees
November 10, 2025
 · 
78 min read
 · 
BioSpace Editorial Staff
Obesity
Despite Obesity Drug Pricing Deal, GLP-1 Compounders Continue To Operate in the Shadows
November 10, 2025
 · 
3 min read
 · 
Dan Samorodnitsky
Digital illustration of human eye color modification and futuristic vision. Made with vector vibrant color gradient geometry form. Isolated on colorful textured background.
Gene therapy
Lilly Doubles Down on Eye Diseases, Adding to BD Spree
November 10, 2025
 · 
1 min read
 · 
Annalee Armstrong